Cytogenetic alterations in gastric MALT lymphomas: Pathogenic significance and clinical correlations;Anomalies cytogénétiques des lymphomes B de la zône marginale de type MALT gastriques: Conséquences physiopathologiques et corrélations cliniques

Hematologie

Volumn 9, Issue 2, 2003, Pages 151-160

  Leroy, Karen ^a   Copie Bergman, Christiane ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

AP12; BCL1O; MALT lymphomas; MALT1

Indexed keywords

CASPASE; CHIMERIC PROTEIN; CYTOPLASM PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN CLAP2; PROTEIN MALT1; UNCLASSIFIED DRUG;

B CELL LYMPHOMA; B LYMPHOCYTE; BACULOVIRUS; BCL10 GENE; CARCINOGENESIS; CELL SPECIFICITY; CHROMOSOME 14; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 14; CLINICAL FEATURE; CORRELATION ANALYSIS; CYTOGENETICS; DISEASE ASSOCIATION; DISEASE MODEL; ERADICATION THERAPY; GENETIC ASSOCIATION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; LYMPH FOLLICLE; LYMPHOMA; MOLECULAR BIOLOGY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATHOGENESIS; PREDICTION; PROTEIN DOMAIN; REVIEW; RISK FACTOR; STOMACH LYMPHOMA; STOMACH MUCOSA; T LYMPHOCYTE;

EID: 0043158862     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997. Hematol J 2000 ; 1: 53-66.
2. Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. MALT Lymphomas. Hematology 2001 ; Am Soc Hematol Educ Program: 241-58.
3. Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L. Ongoing mutation in MALT lymphoma immunoglabulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemía 1996 ; 10: 1190-7.
4. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylari. Lancet 1993 ; 342: 571-4.
5. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7
6. Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, Price H, Karran L, Majekodunmi O, Wlodarska I, Pan L, Crook T, Hamoudi R, Isaacson PG, Dyer MJ. Bcl10 is involved in t(1; 14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999 ; 96: 35-45.
7. Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, Rakestraw KM, Naeve CW, Beckmann G, Weisenburger DD, Sanger WG, Nowotny H, Vesely M, Callet-Bauchu E, Salles G, Dixit VM, Rosenthal A, Schlegelberger B, Morris SW. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 1999 ; 22: 63-8.
8. Du MQ, Peng H, Liu H, Hamoudi RA, Diss TC, Willis TG, Ye H, Dogan A, Wotherspoon AC, Dyer MJ, Isaacson PG. BCL10 gene mutation in lymphoma. Blood 2000 ; 95: 3885-90.
9. Fakruddin JM, Chaganti RS, Murty VV. Lack of BCL10 mutations in germ cell tumors and B cell lymphomas. Cell 1999 ; 97: 683-4.
10. Apostolou S, De Rienzo A, Murthy SS, Jhanwar SC, Testa JR. Absence of BCL10 mutations in human malignant mesothelioma. Cell 1999 ; 97: 684-6.
11. Luminari S, Intini D, Baldini L, Berti E, Bertoni F, Zucca E, Cro L, Maiolo AT, Cavalli F, Neri A. BCL10 gene mutations rarely occur in lymphoid malignancies. Leukemia 2000 ; 14: 905-8.
12. Maes B, Demunter A, Peeters B, De Wolf-Peeters C. BCL 10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression. Blood 2002 ; 99: 1398-404.
13. Reed JC. Mechanism of apoptosis. Am J Pathol 2000; 157: 1415-30.
14. Ruland J, Duncan GS, Elia A, del Barco Barrantes I, Nguyen L, Plyte S, Millar DG, Bouchard D, Wakeham A, Ohashi PS, Mak TW. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 2001 ; 104: 33-42.
15. Yoneda T, Imaizumi K, Maeda M, Yui D, Manabe T, Katayama T, Sato N, Gomi F, Morihara T, Mori Y, Miyoshi K, Hitomi J, Ugawa S, Yamada S, Okabe M, Tohyama M. Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein. J Biol Chem 2000 ; 275: 11114-20.
16. U-BCL10 mice. Blood 2000 ; 96: 822a.
17. Gugasyan R, Grumont R, Grossmann M, Nakamura Y, Pohl T, Nesic D, Gerondakis S. Rel/NF-kappaB transcription factors: key mediators of B-cell activation. Immunol Rev 2000; 176: 134-40.
18. Li X, Stark GR. NFκB-dependent signa]ing pathways. Exp Hematology 2002 ; 30: 285-96.
19. Koseki T, Inohara N, Chen S, Carrio R, Merino J, Hottiger MO, Nobel GJ, Nunez G. CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein El0. J Biol Chem 1999 ; 274: 9955-61.
20. Sun Z, Arendt CW, Ellmeier W, Schaeffer EM, Sunshine MJ, Gandhi L, Annes J, Petrzilka D, Kupfer A, Schwortzberg PL, Littman DR. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 2000 ; 404: 402-7.
21. Levine EG, Arthur DC, Machnicki j, Frizzera G, Hurd D, Peterson B, Gajl-Peczalska KJ, Bloomfield CD. Four new recurring translocations in non-Hodgkin lymphoma. Blood 1989 ; 74: 1796-800.
22. Auer IA, Gascoyne RD, Connors JM, Cotter FE, Greiner TC, Sanger WG, Horsman DE. t(11;18)(q21;q21) is the most common translocation in Malt lymphomas. Ann Oncol 1997 ; 8: 979-85.
23. Remstein ED, James CD, Kurtin PJ. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, and splenic marginal zone lymphomas. Am J Pathol 2000 ; 156: 1183-8.
24. Baens M, Maes B, Steyls A, Geboes K, Marynen P, De Wolf-Peeters C. The product of the t(11;18), an API2-MALT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 2000 ; 156: 1433-9.
25. Dierlamm J, Baens M, Stefanova-Ouzounova M, Hinz K, Wlodarska I, Maes B, Steyls A, Driessen A, Verhoef G, Gaulard P, Hagemeijer A, Hossfeld DK, De Wolf-Peeters C, Marynen P. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood 2000 ; 96: 2215-8.
26. Motegi M, Yonezumi M, Suzuki H, Suzuki R, Hosokawa Y, Hosaka S, Kodera Y, Morishimi Y, Nakamura Y, Seto M. API2-MALT1 chimeric transcripts invalved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 2000 ; 156: 807-12.
27. Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, Isaacson PG, Du M-Q. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that express nuclear BCL10. Blood 2001 ; 98: 1182-7.
28. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999 ; 93: 3601-9.
29. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Biol 2002; 3: 401-10.
30. Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, Koonin EV, Dixit VM. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 2000 ; 6: 961-7.
31. Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF, Yamaoka S, Seto M, Nunez G. Bcl10 and MALT1, Independent targets of chromosomal translocation in MALT Lymphoma, cooperate in a novel NF-κB signaling pathway. J Biol Chem 2001 ; 276: 19012-9.
32. Wang D, You Y, Case SM, McAllister-Lucas LM, Wang L, DiStefano PS, Nunez G, Bertin J, Lin X. A requirement for CARMA1 in TCR-induced NF-kappa B activation. Nat Immunol 2002 ; 3:830-5.
33. Gaide O, Favier B, Legler DF, Bonnet D, Brissoni B, Valitutti S, Bron C, Tschopp J, Thome M. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat Immunol 2002 ; 3: 836-43.
34. Ye H, Dogan A, Karran L, Willis TG, Chen L, Wlodarska I, Dyer MJ, Isaacson PG, Du MQ. BCL1O expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. Am J Pathol 2000 ; 157: 1147-54.
35. Starostik P, Patzner J, Greiner A, Schwarz S, Kalla J, Ott G, Muller-Hermelink HK. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002 ; 99: 3-9.
36. Remstein ED, Kurtin PJ, James CD, Wang X-Y, Meyer RG, Dewald GW. Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am J Pathol 2002 ; 161: 63-71.
37. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, Diss TC, Dogan A, Megraud F, Rambaud JC, Du MQ, Isaacson PG. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001 ; 357: 39-40.
38. Alpen B, Neubauer A, Dierlamm J, Marynen P, Thiede C, Bayerdorfer E, Stolte M. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 2000; 95: 4014-5.
39. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pilerki S, Thiede C, Lavergne A, Boot H, Caletti G, Wundisch T, Molina T, Taal BG, Elena S, Thomas T, Zinzani PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A, Isaacson PG, Du MQ. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002 ; 122: 1286-94.
40. Bertoni F, Conconi A, Capella C, Motta T, Giardini R, Ponzoni M, Pedrinis E, Novero D, Rinaldi P, Cazzaniga G, Biondi A, Wotherspoon A, Hancock BW, Smith P, Souhami R, Cotter FE, Cavalli F, Zucca E. International Extranodal Lymphoma Study Group. United Kingdom Lymphoma Group. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood 2002 ; 99 : 2541-4.
41. Neumeister P, Hoefler G, Beham-Schmid C, Schmidt H, Apfelbeck U, Schaider H, Linkesch W, Sill H. Deletion analysis of the p 16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas. Gastroenterology 1997 ; 112 : 1871-5.
42. Du M, Peng H, Singh N, Isaacson PG, Pan L. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 1995 15 ; 86 : 4587-93